Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway

Cardiovascular Research

Volumn 86, Issue 1, 2010, Pages 103-112

  Gurusamy, Narasimman ^a   Lekli, Istvan ^a   Mukherjee, Subhendu ^a   Ray, Diptarka ^a   Ahsan, Md Kaimul ^a   Gherghiceanu, Mihaela ^b   Popescu, Lawrence M ^b   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Autophagy; Cardioprotection; Cell survival; mTOR; Resveratrol; Rictor

Indexed keywords

3 METHYLADENINE; ANTIOXIDANT; MAMMALIAN TARGET OF RAPAMYCIN; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; RAPAMYCIN; RESVERATROL; SERINE; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INHIBITION; GRAPE; HEART MUSCLE CELL; HEART PROTECTION; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; MALE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RED WINE; REOXYGENATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; CARDIOTONIC AGENTS; CARRIER PROTEINS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOBLASTS, CARDIAC; MYOCARDIUM; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TRANSCRIPTION FACTORS;

EID: 77949357437     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp384     Document Type: Article

References (53)

1. Powell SR. The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 2006;291:H1-H19.
2. Gustafsson AB, Gottlieb RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 2008;44:654-661.
3. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-1036.
4. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107: 984-991.
5. Hein S, Elsasser A, Kostin S, Zimmermann R, Schaper J. Functional disturbances due to structural remodeling in the failing human heart. Arch Mal Coeur Vaiss 2002;95: 815-820.
6. Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma H. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 2001;65:965-968.
7. Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007;117: 1782-1793.
8. Gurusamy N, Lekli I, Gorbunov N, Gherghiceanu M, Popescu LM, Das DK. Cardioprotection by adaptation to ischemia augments autophagy in association with BAG-1 protein. J Cell Mol Med 2008;13:375-389.
9. Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006;281: 29776-29787.
10. Gurusamy N, Lekli I, Gherghiceanu M, Popescu LM, Das DK. BAG-1 induces autophagy for cardiac cell survival. Autophagy 2009;5:120-121.
11. Gurusamy N, Das DK. Autophagy, redox signaling and ventricular remodeling. Antioxid Redox Signal 2009;11:1975-1988.
12. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26:1749-1760.
13. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 2006;6:36-47.
14. Dudley J, Das S, Mukherjee S, Das DK. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem 2009;20:443-452.
15. Das S, Cordis GA, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. Am J Physiol Heart Circ Physiol 2005;288:H328-H335.
16. Opipari AW Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 2004;64: 696-703.
17. Trincheri NF, Follo C, Nicotra G, Peracchio C, Castino R, Isidoro C. Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes. Carcinogenesis 2008;29:381-389.
18. Biederbick A, Kern HF, Elsasser HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 1995;66:3-14.
19. Gherghiceanu M, Hinescu ME, Popescu LM. Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice. J Cell Mol Med 2009;13:202-206.
20. Popescu LM, Gherghiceanu M, Hinescu ME, Cretoiu D, Ceafalan L, Regalia T et al. Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC). J Cell Mol Med 2006;10:429- 458.
21. Samari HR, Seglen PO. Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J Biol Chem 1998;273: 23758-237563.
22. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-1101.
23. Gustafsson AB, Gottlieb RA. Eat your heart out: role of autophagy in myocardial ischemia/reperfusion. Autophagy 2008;4:416-421.
24. Matsui Y, Kyoi S, Takagi H, Hsu CP, Hariharan N, Ago T et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008;4:409-415.
25. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN, Kim L et al. A method to measure cardiac autophagic flux in vivo. Autophagy 2008;4:322-329.
26. Neufeld TP. Contribution of Atg1-dependent autophagy to TOR-mediated cell growth and survival. Autophagy 2007;3:477-479.
27. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005;17:596-603.
28. Martin DE, Hall MN. The expanding TOR signaling network. Curr Opin Cell Biol 2005; 17:158-166.
29. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006;22:159-168.
30. Goswami SK, Das DK. Autophagy in the myocardium: dying for survival? Exp Clin Cardiol 2006;11:183-188.
31. Buller CL, Loberg RD, Fan MH, Zhu Q, Park JL, Vesely E et al. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol 2008;295:C836-C843.
32. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004;24:200-216.
33. Horman S, Beauloye C, Vertommen D, Vanoverschelde JL, Hue L, Rider MH. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J Biol Chem 2003;278:41970- 41976.
34. Brito PM, Devillard R, Negre-Salvayre A, Almeida LM, Dinis TC, Salvayre R et al. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 2009;205:126- 134.
35. Scott RC, Schuldiner O, Neufeld TP. Role and regulation of starvation-induced autophagy in the Drosophila fat body. Dev Cell 2004;7:167-178.
36. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;61:427-436.
37. Attaix D, Bechet D. FoxO3 controls dangerous proteolytic liaisons. Cell Metab 2007; 6:425-427.
38. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H. Resveratrol improves nonalcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 2008;29:698-706.
39. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D et al. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/AKT/eNOS signaling pathway in diabetic myocardium. J Cell Mol Med 2008;12:2350-2361.
40. Hwang JT, Kwon DY, Park OJ, Kim MS. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2008;2:323-326.
41. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007;100:914-922.
42. Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J. AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 2007;3:405-407.
43. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002;277:23977-23980.
44. Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 2006;574:63-71.
45. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 2003;278:39422-39427.
46. Huang J, Manning BD. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 2009;37:217-222.
47. Wan X, Harkavy B, Shen N, Grohar P, Helman LJ. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 2007;26: 1932-1940.
48. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006;119:259-270.
49. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 1997;243:240- 246.
50. Kueck A, Opipari AWJr, Griffith KA, Tan L, Choi M, Huang J et al. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007;107:450-457.
51. Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008;15:1318-1329.
52. Lizcano JM, Alrubaie S, Kieloch A, Deak M, Leevers SJ, Alessi DR. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B. Biochem J 2003;374:297-306.
53. Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell 2006;24: 185-197.